Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Group 1: Talos Energy Overview - Talos Energy (TALO) currently holds a Momentum Style Score of B and a Zacks Rank of 2 (Buy) [3][4] - The Zacks Rank system has a strong track record, indicating that stocks rated 1 (Strong Buy) and 2 (Buy) with Style Scores of "A or B" tend to outperform the market in the following month [4] Group 2: Price Performance - TALO shares have increased by 4.28% over the past week, outperforming the Zacks Oil and Gas - Exploration and Production - United States industry, which rose by 2.89% [6] - Over the past month, TALO's price change is 14.16%, significantly higher than the industry's 3.46% [6] - In the last quarter, TALO shares rose by 23.44%, and over the past year, they gained 19.94%, while the S&P 500 increased by only 6.25% and 14.29%, respectively [7] Group 3: Trading Volume - TALO's average 20-day trading volume is 2,053,107 shares, which serves as a price-to-volume baseline; a rising stock with above-average volume is generally seen as bullish [8] Group 4: Earnings Outlook - In the past two months, three earnings estimates for TALO have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from -$1.05 to -$0.67 [10] - For the next fiscal year, three estimates have also moved upwards without any downward revisions [10] Group 5: Investment Recommendation - Given the positive momentum indicators and earnings outlook, TALO is recommended as a stock to consider for near-term investment opportunities [12]

Company Overview - Rapport Therapeutics, Inc. (RAPP) currently holds a Momentum Style Score of B and a Zacks Rank of 2 (Buy) [3][4] - The company has shown strong price performance, with shares up 9.03% over the past week and 14.97% over the past month, outperforming the Zacks Medical - Biomedical and Genetics industry, which is up 5% and 3.48% respectively [6] Price Performance - Over the past quarter, RAPP shares have risen 24.16%, and over the last year, they are up 44.18%, significantly outperforming the S&P 500, which has moved 6.25% and 14.29% respectively [7] - The average 20-day trading volume for RAPP is 361,157 shares, indicating a bullish trend as the stock is rising with above-average volume [8] Earnings Outlook - In the past two months, 4 earnings estimates for RAPP have moved higher, while none have moved lower, resulting in an increase in the consensus estimate from -$3.01 to -$2.79 [10] - For the next fiscal year, 4 estimates have also moved upwards with no downward revisions during the same period, indicating positive sentiment around the company's earnings potential [10] Conclusion - Given the strong momentum indicators and positive earnings outlook, RAPP is positioned as a promising investment opportunity for those seeking stocks with potential for near-term growth [12]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Theravance Biopharma (TBPH) - Theravance Biopharma currently holds a Momentum Style Score of A, indicating strong momentum characteristics [3] - The company has a Zacks Rank of 2 (Buy), suggesting a favorable outlook based on historical performance metrics [4] Performance Metrics - TBPH shares have increased by 9.85% over the past week, outperforming the Zacks Medical - Drugs industry, which rose by 4.47% during the same period [6] - Over the past month, TBPH's price change is 25.76%, significantly higher than the industry's 0.88% [6] - In the last quarter, TBPH shares rose by 29.72%, and over the past year, they have gained 87.75%, while the S&P 500 increased by only 6.25% and 14.29%, respectively [7] Trading Volume - TBPH's average 20-day trading volume is 594,234 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the last two months, 2 earnings estimates for TBPH have been revised upwards, while only 1 estimate was revised downwards, leading to an increase in the consensus estimate from -$0.06 to $0.24 [10] - For the next fiscal year, 3 estimates have moved upwards with no downward revisions, indicating positive sentiment regarding future earnings [10] Conclusion - Given the strong momentum indicators and positive earnings outlook, TBPH is positioned as a promising investment opportunity with a Momentum Score of A and a Zacks Rank of 2 (Buy) [12]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1][2]. Company Overview: PLBY Group, Inc. - PLBY Group, Inc. currently holds a Momentum Style Score of B and a Zacks Rank of 2 (Buy), indicating strong potential for outperformance in the market [3][4]. - The stock has shown significant price increases, with shares up 12.28% over the past week and 66.15% over the past month, outperforming the Zacks Leisure and Recreation Products industry, which saw increases of 5.62% and 1.03% respectively [6]. - Over the past quarter, PLBY shares have risen 34.16%, and over the last year, they are up 41.18%, compared to the S&P 500's increases of 6.25% and 14.29% [7]. Trading Volume - The average 20-day trading volume for PLBY is 886,470 shares, which serves as a bullish indicator when combined with rising stock prices [8]. Earnings Outlook - Recent earnings estimate revisions for PLBY show one upward revision for the full year, increasing the consensus estimate from -$0.19 to -$0.13 over the past 60 days, with similar positive trends for the next fiscal year [10]. Conclusion - Given the strong momentum indicators and positive earnings outlook, PLBY Group, Inc. is positioned as a promising investment opportunity [12].

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Hecla Mining (HL) - Hecla Mining currently holds a Momentum Style Score of B, indicating a positive momentum outlook [2] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [3] Performance Metrics - Over the past week, HL shares have increased by 25.71%, outperforming the Zacks Mining - Silver industry, which rose by 25.01% [5] - In a longer timeframe, HL shares have gained 51.38% over the past quarter and 207.43% over the last year, significantly outperforming the S&P 500's increases of 6.25% and 14.29% respectively [6] Trading Volume - The average 20-day trading volume for HL is 15,940,757 shares, indicating a bullish sentiment when combined with rising stock prices [7] Earnings Outlook - In the past two months, two earnings estimates for HL have been revised upwards, increasing the consensus estimate from $0.33 to $0.38 [9] - For the next fiscal year, two estimates have also moved higher, with no downward revisions noted [9] Conclusion - Considering the positive momentum indicators and earnings outlook, HL is positioned as a solid momentum pick with a 2 (Buy) rating and a Momentum Score of B [11]

Core Insights - Zacks Premium offers various tools for investors to enhance their stock market strategies and confidence in investing [1] - The Zacks Style Scores are designed to help investors select stocks with the highest potential to outperform the market in the short term [2] Zacks Style Scores Overview - The Style Scores categorize stocks into four main types: Value Score, Growth Score, Momentum Score, and VGM Score, each focusing on different investment strategies [3][4][5][6] - Value Score identifies undervalued stocks using financial ratios [3] - Growth Score assesses a company's financial health and future growth potential [4] - Momentum Score evaluates stocks based on price trends and earnings estimate changes [5] - VGM Score combines all three styles to highlight stocks with the best overall characteristics [6] Zacks Rank and Performance - The Zacks Rank is a proprietary model that leverages earnings estimate revisions to guide investors in stock selection [7] - Stocks rated 1 (Strong Buy) have historically achieved an average annual return of +23.93%, significantly outperforming the S&P 500 [8] - A total of over 800 stocks are rated highly, making it essential for investors to utilize Style Scores to refine their choices [9] Stock Example: Paylocity (PCTY) - Paylocity Holding Corporation, a provider of cloud-based payroll and HCM solutions, is currently rated 3 (Hold) with a VGM Score of B [11] - The stock has a Momentum Style Score of A, with a recent price increase of 3.3% over the past month [11] - Analysts have raised earnings estimates for fiscal 2026, with the consensus now at $7.34 per share, reflecting an average earnings surprise of +13.8% [12]

Core Viewpoint - Momentum investing focuses on "buying high and selling higher," contrasting with traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Characteristics - Momentum investing can be risky as stocks may lose momentum when their valuations exceed future growth potential [2] - Investing in bargain stocks with recent price momentum may be a safer approach [3] Group 2: Select Medical (SEM) Analysis - Select Medical (SEM) has shown a four-week price change of 11.9%, indicating strong investor interest [4] - SEM has gained 19.2% over the past 12 weeks, with a beta of 1.28, suggesting it moves 28% higher than the market [5] - SEM has a Momentum Score of B, indicating a favorable time to invest [6] Group 3: Earnings Estimates and Valuation - An upward trend in earnings estimate revisions has contributed to SEM's Zacks Rank 2 (Buy), which is associated with strong momentum effects [7] - SEM is trading at a Price-to-Sales ratio of 0.34, indicating it is relatively cheap at present [7] Group 4: Additional Investment Opportunities - Other stocks also meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, suggesting further investment opportunities [8] - Zacks offers over 45 Premium Screens to assist in identifying winning stock picks based on various investing styles [9]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Rio Tinto (RIO) - Rio Tinto currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for potential outperformance in the market [3] Price Performance - Over the past week, Rio Tinto shares increased by 2.8%, while the Zacks Mining - Miscellaneous industry rose by 11.75% [5] - In a longer timeframe, shares have risen by 6.44% over the past month, compared to the industry's 12.16% [5] - Over the last quarter, Rio Tinto shares increased by 17.89%, and by 16.07% over the past year, outperforming the S&P 500, which moved 5.77% and 13.9% respectively [6] Trading Volume - The average 20-day trading volume for Rio Tinto is 2,285,208 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, two earnings estimates for Rio Tinto have been revised upwards, with the consensus estimate increasing from $6.04 to $6.32 [9] - For the next fiscal year, two estimates have also moved upwards, with no downward revisions during the same period [9] Conclusion - Considering the strong momentum indicators and positive earnings outlook, Rio Tinto is recommended as a 2 (Buy) stock with a Momentum Score of A, making it a potential candidate for near-term investment [11]

Core Viewpoint - Aurinia Pharmaceuticals (AUPH) is identified as a promising momentum stock, currently holding a Momentum Style Score of B and a Zacks Rank of 2 (Buy) [3][4][12] Momentum Style Score - The Zacks Momentum Style Score incorporates price changes and earnings estimate revisions to evaluate stocks [2][9] - AUPH's shares have increased by 19.8% over the past quarter and 72.41% over the last year, significantly outperforming the S&P 500, which moved 5.77% and 13.9% respectively [7] Price Performance - AUPH shares are up 2.81% over the past week, while the Zacks Medical - Drugs industry has increased by 4.43% during the same period [6] - The monthly price change for AUPH is 9.75%, compared to the industry's 1.34% performance [6] Trading Volume - AUPH's average 20-day trading volume is 1,763,778 shares, indicating a bullish sign as it reflects current interest in the stock [8] Earnings Outlook - Over the past two months, 4 earnings estimates for AUPH have moved higher, with no downward revisions, increasing the consensus estimate from $0.62 to $0.78 [10] - For the next fiscal year, 4 estimates have also moved upwards without any downward revisions [10]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Hamilton Insurance (HG) - Hamilton Insurance currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 1 (Strong Buy), suggesting a favorable outlook compared to the market [3] Price Performance - Over the past week, HG shares increased by 1.15%, while the Zacks Insurance - Multi line industry rose by 1.41% [5] - In a longer timeframe, HG's monthly price change is 3.04%, outperforming the industry's 2.43% [5] - Over the last quarter, HG shares have risen by 9.02%, and by 37.31% over the past year, compared to the S&P 500's increases of 5.77% and 13.9%, respectively [6] Trading Volume - HG's average 20-day trading volume is 476,906 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, one earnings estimate for HG has increased, raising the consensus estimate from $3.16 to $3.98 [9] - For the next fiscal year, one estimate has also moved upwards, with no downward revisions during the same period [9] Conclusion - Given the strong momentum score and positive earnings outlook, Hamilton Insurance is positioned as a promising investment opportunity [11]